Farmacogenómica de los anticoagulantes orales: la importancia de establecer algoritmos de dosificación en población chilena

Guzmán, Neftalí; Vega, Mario; Reyes, Franco; Guzmán-Oyarzo, Dina; Andaur, Marcela; Boguen, Rodrigo; Letelier, Pablo.
Rev. méd. Chile ; 148(9)sept. 2020.
Artículo en Español | LILACS | ID: biblio-1389314

Documentos relacionados

  1. [Pharmacogenomics of vitamin K antagonists].
  2. Optimisation of warfarin-dosing algorithms for Han Chinese patients with CYP2C9*13 variants.
  3. Pharmacogenetic distinction of the Croatian population from the European average.
  4. Association between polymorphisms of the VKORC1 and CYP2C9 genes and warfarin maintenance dose in Peruvian patients.
  5. A clinical study of genetic testing to guide the dosing of warfarin after heart valve replacement.
  6. Targeted next-generation sequencing of genes involved in Warfarin Pharmacodynamics and pharmacokinetics pathways using the Saudi Warfarin Pharmacogenetic study (SWAP).
  7. Kinetic-pharmacodynamic model of warfarin for prothrombin time-international normalized ratio in Japanese patients.
  8. Synergy of Mutation-Induced Effects in Human Vitamin K Epoxide Reductase: Perspectives and Challenges for Allo-Network Modulator Design.
  9. Association between CYP2C9 and VKORC1 genetic polymorphisms and efficacy and safety of warfarin in Chinese patients.
  10. Effect of NPC1L1 polymorphism on warfarin stable dose in Chinese patients under heart valve replacement surgery.